CORRECTION: Arena Pharmaceuticals Awaits FDA Advisory
CORRECTION: Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting
LOS ANGELES, CALIFORNIA -- (Marketwire) -- 05/07/12 -- Marketwire issued a news release earlier today on behalf of Arena Pharmaceuticals, Inc. (NASDAQ;ARNA) in error entitled, "Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting". This release was issued without the approval of Arena Pharmaceuticals, Inc. Editors and other readers are advised to disregard this news release.
Marketwire regrets any inconvenience this may have caused. Contacts: Legitimate Market, Inc. Market Research 250-448-1807